This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB02916/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02916/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n6http://linked.opendata.cz/resource/drugbank/drug/DB02916/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02916/identifier/drugbank/
n7http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02916
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n4:DB02916 n11:DB02916
dcterms:title
[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate
adms:identifier
n6:46508884 n9:LMS n10:46936528 n12:DB02916
n7:IUPAC-Name
n8:271B64E2-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B64E8-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B64E7-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B64E4-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B64E5-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B64E6-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B64E0-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B64DE-363D-11E5-9242-09173F13E4C5 n8:271B64E1-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B64DF-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B64EE-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B64EF-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B64E9-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B64EA-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B64EC-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B64EB-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B64ED-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B64F4-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B64F6-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B64F7-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B64F3-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B64F2-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B64F5-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B64E3-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B64F0-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B64F1-363D-11E5-9242-09173F13E4C5